Success Story: Despite RFE! Our Firm Assisted a Bangladeshi Graduate Teaching Assistant Secure NIW Approval

Client’s Testimonial:

“I’m grateful to the law firm for taking my case and supporting me throughout the I-140 process. They responded promptly, provided clear answers with evidence, and acted quickly when I received an RFE. Thanks to their professionalism and dedication, my case was approved. Thank you to the entire team!”

On January 30^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Teaching Assistant in the Field of Pharmacology (Approval Notice).

General Field: Pharmacology

Position at the Time of Case Filing: Graduate Teaching Assistant

Country of Origin: Bangladesh

State of Residence at the Time of Filing: Wisconsin

Approval Notice Date: January 30^th, 2025

Processing Time: 6 months, 27 days (Premium Processing Requested)

Case Summary:

NAILG is pleased to announce the approval of an EB-2 National Interest Waiver (NIW) petition for a pharmacology researcher advancing critical biomedical discoveries. At the time of filing, the client was pursuing her proposed endeavor of leveraging sophisticated biochemical techniques to investigate the interaction between LSD1 and RNA-DNA hybrids. Her research provides novel insights into how these molecular mechanisms influence gene expression and contribute to the pathology of Ewing sarcoma, a rare and aggressive childhood cancer. By advancing knowledge in this area, her work supports the development of targeted therapies with fewer side effects, directly addressing urgent needs in cancer treatment and public health.

Research with Substantial Merit and National Importance
We demonstrated that the client’s research is of both substantial merit and national importance. Ewing sarcoma presents significant clinical and socioeconomic challenges, with limited effective treatment options and high relapse rates. Her studies contribute to improving therapeutic strategies, reducing recurrence, and ultimately saving lives. Beyond individual health outcomes, this work alleviates the broader financial and social burden of cancer care in the United States. By tackling a disease with profound medical and economic implications, her research directly aligns with national priorities to strengthen healthcare innovation and patient outcomes.

Evidence of Accomplishments
To support the petition, NAILG highlighted the client’s impressive academic and research record, including:

7 peer-reviewed journal articles (1 of them first-authored).
27 citations to her published work, reflecting recognition by other experts.

Her research has also been cited by other scholars studying diabetes therapies, cancer prevention, and the medicinal benefits of natural compounds, underscoring its broad applicability and influence across pharmacological science.

Recognition and Expert Support
Further strengthening the case, the petition included two independent recommendation letters from experts in the field. These letters attested to her unique methodologies, her proven ability to advance pharmacological science, and the national importance of her contributions. One recommender noted:

“Her knowledge and expertise make Client a significant figurehead in advancing medicinal techniques and practices, and it is unlikely any other researcher can compare to her remarkable skill set.”

NIW Approval and Outlook
USCIS approved the petition after recognizing that the client is well-positioned to continue advancing her proposed endeavor and that waiving the job offer and labor certification requirements is in the national interest. With NAILG’s support, the petition demonstrated her consistent record of impactful research and her potential to generate new therapeutic strategies for cancer treatment. This approval enables her to continue her vital work in pharmacology, advancing drug discovery and contributing to the nation’s biomedical innovation.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.